Australian and New Zealand Urogenital and Prostate Cancer Trials Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Camperdown Australia (2008)

Organization Overview

First Clinical Trial
2013
NCT02948543
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Australian and New Zealand Urogenital and Prostate Cancer Trials Group | Australian & New Zealand Urogenital & Prostate Cancer Trials Group